Legato Merger Corp III LEGT Q1 2026 Earnings Minimal Activity as SPAC Holds Cash Reports Positive EPS WEC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower XPEL Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment Telomir Pharmaceuticals TELO Q4 2025 Earnings WiderthanExpected Loss Amid Ongoing Development TPR Q1 2026 Earnings EPS Exceeds Estimates by 26